Ravikiran Namburi
Hyderabad
Summary
Entrepreneurial & Driven Executive| Business Transformation| P&L Expertise
32 years of experience in Pharma industry|15 years in P&L role| Specialize in Business Transformation and Global Expansion| Expertise of handling large cross functional teams of 1200 plus| Handled 200 MIO USD plus-business at global level| Strategic, Growth & Result oriented| Hands on experience of delivering year on year high double-digit growths in top line and bottom lines| Marketing, Sales, Regulatory, Manufacturing, SCM, Logistics, Finance functions.
Overview
34
34
years of professional experience
Work History
Chief Business Officer (Emerging & Domestic Markets)
Aurobindo Pharma Ltd
03.2023 - Current
- Spear Heading Formulations business of Aurobindo Pharma and their Subsidiaries in India South East Asia, South Asia, South Africa, MENA GCC, Africa, CIS Russia Regions since Mar 24
- Delivered high double-digit growth, Topline & Bottom Line through transformational and expansion strategies in Emerging markets
- Turned around APAC & GCC MENA business through new alliances and partnerships
- Aggressive expansion and Alliances planned in South Africa for doubling the business in 3 years
- Successfully integrated Viatris business in to APL after acquisition with business and people level strategies in Indonesia.
- Successful acquisition on the cards in Russia to ensure local manufacturing
- Successfully supporting operations in LATAM, Europe B@B and ARV business
- Ensured Domestic business to deliver high profits with strategic interventions
- Managed successful integration of GLS Pharma acquisition including Plant, Manufacturing, Operations, Marketing, Sales & Finance functions as board member
- Expanded domestic business in new therapy areas to with a vision to reach 500 Cr in 3 years
Business Head (India & South Asia)
Natco Pharma Ltd
10.2021 - 02.2024
- Handling Super Specialty and Specialty business in Acute, Sub Chronic and Chronic of Oncology, Gastro, HIV, Ortho/Rheuma, Critical Care, Cardio & Diabetes.
- Team size of 850 Plus in India of all 3 BU’s and 7 Divisions, business of 450 Cr
- Handling South Asia region and Unregulated Market business of 250 Cr
- Reporting to Vice Chairman & CEO, with complete Domestic Operations team reporting
- Established Structural, Strategic and Operational direction to the business to ensure better penetration for gaining MS and Ranks through Internal customer motivation and External customer engagement plans
- Carved new division for Organic growth with Focused approach and portfolio building
- Prepared 5-year Vison plan to grow Domestic business in lines with Global, Ensuring Inorganic growth through acquisition plans, which are on final stage
Vice President & Cluster Head
Cadila Pharma
01.2020 - 09.2021
- Head Chronic cluster with 5 BUs of Cardio/Diabetic, Critical Care, Ortho/Rhuema, Derma & Onco
- Techno Commercial role, 1200 Plus team, 450 Cr Plus business, with reporting of Cross functional team comprising senior managers from Finance, HR, L&D, Medical, Supply Chain, Demand Planning, Distribution, SFE, Strategy, BD and New Product Development
- Determine strategic direction, identify and implement growth drivers to achieve objectives with large, demotivated team
- Ensured topline and bottom-line growth with brand building initiatives
Director
Cipla Ltd
Mumbai
01.2019 - 12.2019
- Business head as BU Director handling 2 business units of Cardiology portfolio In house and In license brands.
- Strategic and P&L role, 600 Plus team,250 Cr plus business size
- Spearhead strategic team in a project with external agency Meckensy provide long term vision, structure and direction to chronic portfolio
- Maintain & Strengthen business ties within License partner (Novartis HC) for long term
- Successfully handle two diverse teams and ensured MS& Rank improvement from 15 to 9 with brand building and CRM activities of In-House brands
- Achieved aggressive growths 50% plus of In license brands from Novartis Health Care
- Mumbai
General Manager
Alkem Labs
Mumbai
03.2016 - 12.2018
- BU Head with P&L responsibility Cardiology team
- P&L role of Cardiology team with 350 members and 200 Cr Business
- Revive the business with systems and process, create novel review mechanism to improve outcomes
- Improve ROI and to ensure profitability
- Enhance market share, improve rank in RPM with top line and bottom-line objective achievements
- Key Achievements
- Revived business in two quarters with new SOPs, Review & tracking mechanisms
- ROI improved with bottom-up approach and involvement of field managers in the process
- Market share and Ranks improved from 23 to 15 in RPM.
- Delivered EBITA (bottom line) growth more than double digit for the first time in division, 3 years consecutively after
- Field personal strength improved from 200 to 350 and launched new task force team with 60 members
- Mumbai
Head Sales & Marketing
Wockhardt Ltd
Mumbai
06.2013 - 02.2016
- P&L Role with Sales & Marketing, Diabetes & Cardio
- Created a new team for Human Insulin portfolio with 150 members
- Established the division separately from existing Diabetes portfolio business grew 0 to 5 crores per month in 6 months
- Aggressive new strategies at Key Hospitals across India, E Commerce plat forms (Flipkart etc) and Digital media campaigns to establish Sugar Check as brand
- Expanded and created 3 teams with Orals, Human and Synthetic insulin separately and achieved profits for the first time as NSM 13-14 period
- Mumbai
Sales Manager
Novartis Health Care
Mumbai
01.2009 - 05.2013
- Sales Head, West & South zones for CVM Portfolio
- To achieve topline and bottom line with Galvus in aggressive DPP4 market and high-end Cardio portfolio in West zone
- Improve market share and rank of Galvus/Galvusmet in DPP4 market of West zone
- Maintain no 1 MS and ranks in South zone with top line achievement and deliver planned growth
- Launch Galvus Portfolio and Establish CVM division in South zone as ZSM
- Awarded as Best Sales Manager for low Attrition & People Development 2012
- Successfully launched in 2009 Galvus and CVM Portfolio in South zone delivered 100% growth year on year for 3 years as ZSM based at Bangalore
- Mumbai
FSO to ZSM
Novartis India Ltd
01.1997 - 01.2009
Med Rep
Sandoz India Ltd
01.1992 - 01.1997
Education
B Pharm -
PGDMM -
IGNOU
PGDM -
NMIMS
Doctor In Business Administration - Persuing
GGU
San FranciscoSkills
- Strategic
- Growth
- Result oriented
- Marketing
- Sales
- Regulatory
- Manufacturing
- SCM
- Logistics
- Finance
Languages
- English
- Hindi
- Telugu
- Kannada
- Tamil
Personal Information
Date of Birth: 04/25/67
Career Path
- Novartis India Ltd, FSO to ZSM, Bangalore, 1997-2009, Ortho Super Specialty, Gy/Obs
- Sandoz India Ltd, Med Rep, 1992-1997, Nutrition, Gy/Obs, Cardio & Neuro
Timeline
Chief Business Officer (Emerging & Domestic Markets)
Aurobindo Pharma Ltd
03.2023 - Current
Business Head (India & South Asia)
Natco Pharma Ltd
10.2021 - 02.2024
Vice President & Cluster Head
Cadila Pharma
01.2020 - 09.2021
Director
Cipla Ltd
01.2019 - 12.2019
General Manager
Alkem Labs
03.2016 - 12.2018
Head Sales & Marketing
Wockhardt Ltd
06.2013 - 02.2016
Sales Manager
Novartis Health Care
01.2009 - 05.2013
FSO to ZSM
Novartis India Ltd
01.1997 - 01.2009
Med Rep
Sandoz India Ltd
01.1992 - 01.1997
B Pharm -
PGDMM -
IGNOU
PGDM -
NMIMS
Doctor In Business Administration - Persuing
GGU